Cited by 3,274Cytokine Signaling Pathways and InteractionsProtein Tyrosine PhosphatasesNF-κB Signaling Pathways

Principles of interleukin (IL)-6-type cytokine signalling and its regulation

Open access
HEINRICH, Peter C., BEHRMANN, Iris, HAAN, Serge, HERMANNS, Heike M., MÜLLER-NEWEN, Gerhard, SCHAPER, Fred·2003·Biochemical Journal

Abstract

The IL (interleukin)-6-type cytokines IL-6, IL-11, LIF (leukaemia inhibitory factor), OSM (oncostatin M), ciliary neurotrophic factor, cardiotrophin-1 and cardiotrophin-like cytokine are an important family of mediators involved in the regulation of the acute-phase response to injury and infection. Besides their functions in inflammation and the immune response, these cytokines play also a crucial role in haematopoiesis, liver and neuronal regeneration, embryonal development and fertility. Dysregulation of IL-6-type cytokine signalling contributes to the onset and maintenance of several diseases, such as rheumatoid arthritis, inflammatory bowel disease, osteoporosis, multiple sclerosis and various types of cancer (e.g. multiple myeloma and prostate cancer). IL-6-type cytokines exert their action via the signal transducers gp (glycoprotein) 130, LIF receptor and OSM receptor leading to the activation of the JAK/STAT (Janus kinase/signal transducer and activator of transcription) and MAPK (mitogen-activated protein kinase) cascades. This review focuses on recent progress in the understanding of the molecular mechanisms of IL-6-type cytokine signal transduction. Emphasis is put on the termination and modulation of the JAK/STAT signalling pathway mediated by tyrosine phosphatases, the SOCS (suppressor of cytokine signalling) feedback inhibitors and PIAS (protein inhibitor of activated STAT) proteins. Also the cross-talk between the JAK/STAT pathway with other signalling cascades is discussed.

AI snapshot

Written from the paper’s full text.

TL;DR

This review summarizes IL-6-type cytokine signalling through gp130, LIFR and OSMR, covering JAK/STAT and MAPK activation and the mechanisms that terminate or modulate these pathways. It emphasizes negative regulation by tyrosine phosphatases, SOCS feedback inhibitors and PIAS proteins, as well as cross-talk with other signalling cascades.

Key findings

  • IL-6-type cytokines (IL-6, IL-11, LIF, OSM, CNTF, CT-1 and CLC) signal via gp130 homodimers or gp130–LIFR/OSMR heterodimers; all potently activate STAT3 and, to a lesser extent, STAT1 through gp130, while OSMR is the most potent activator of STAT5.
  • Receptor activation requires more than simple dimerization: efficient gp130 activation by monoclonal antibodies required two distinct antibodies, with the minimal requirement being one intact antibody plus the Fab of a second; insertion of one to four alanines into the gp130 membrane-proximal intracellular region gave full activation only with wild-type and the +3A mutant, interpreted as an approx. 110° twist per alanine and approx. 330° for three.
  • JAK1 is essential for IL-6 signalling; gp130, LIFR and OSMR bind JAK1, JAK2 and TYK2. JAK1 mobility is approx. 100-fold lower than that of a typical cytoplasmic protein, and gp130 residues including box1 prolines and Trp666 are critical for JAK binding, while W652A abrogates JAK1 activation without affecting JAK1 association.
  • Signal termination involves SHP2 and SOCS3 at gp130 pTyr759, with SOCS3 binding gp130 peptides with slightly higher affinity than SHP2; SOCS1 and SOCS3 inhibit JAKs, PIAS1 inhibits STAT1 and PIAS3 inhibits STAT3. Reported half-lives include SOCS1 1.5 h, SOCS2 1 h, SOCS3 1.6 h, IL-6Rα 2–3 h, gp130 2.5 h, JAK1 3.2 h, JAK2 1.9 h, TYK2 2 h, STAT3α 8.5 h, STAT3β 4.5 h, STAT1 16 h and SHP-2 18–20 h.

Methods

  • Narrative review of molecular mechanisms of IL-6-type cytokine signal transduction, focusing on advances made during the previous 5 years in receptor activation, JAK–receptor interactions, STAT activation, signal modulation and cross-talk.
  • Synthesizes structural, mutagenesis, biochemical and in vivo findings from the literature; no primary experimental dataset is presented, and the text includes models and a table of half-lives drawn from cited studies.

Limitations

  • The authors state that key structural data are still missing, including the structure and conformational states of the cytoplasmic parts of cytokine receptors, and that three-dimensional structures of JAKs and SOCS proteins would be extremely valuable.
  • The authors state that mathematical models of this complexity suffer from a lack of sufficient quantitative experimental data, and that cross-talk and biological outcomes depend on cell type and differentiation state.
  • Evident from the text: as a narrative review, it does not use a systematic search or meta-analysis, and it includes unpublished work/personal communications and unresolved conflicting findings, such as JNK versus p38 involvement in STAT3 Ser727 phosphorylation and the positive versus negative regulatory functions reported for STAT3β.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1042/bj20030407

Cites

269 of 269 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Claims the paper makes

0 of 253 cited sources checked · 0 supported · 0 flagged

  • Premisecitation

    Human OSM forms both LIFR-gp130 and OSMR-gp130 heterodimers.

    “Human OSM has the exceptional capability to recruit two different receptor complexes.It forms both LIFR-gp130 and OSMR-gp130 heterodimers.”
    Quote in the paperNot a substantial claim0 of 2 sources checked
    • cites [4]

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

    • cites [6]

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

  • Premisecitation

    LIF and OSM directly engage their signalling receptor subunits without requirement for additional α-receptor subunits.

    “LIF and OSM directly engage their signalling receptor subunits without requirement for additional α-receptor subunits (Figure 2) [4,6].”
    Quote in the paperNot a substantial claim0 of 2 sources checked
    • cites [4]

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

    • cites [6]

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

  • Premisecitation

    Soluble forms of cytokine receptors in vivo are formed either by limited proteolysis (shedding) of membrane-bound receptors or by translation from an alternatively spliced mRNA.

    “Soluble forms of cytokine receptors in vivo are formed either by limited proteolysis (shedding) of membrane-bound receptors or by translation from an alternatively spliced mRNA [4].”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [4]

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

  • Premisecitation

    sIL-6Rα potentiates the antagonistic activity of sgp130.

    “It has been demonstrated that sIL-6Rα potentiates the antagonistic activity of sgp130.”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [7]

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

  • Premisecitation

    In contrast with IL-6, and presumably also IL-11, where all the helices are straight, the A helix of LIF, OSM and CNTF is kinked.

    “In contrast with IL-6, and presumably also IL-11, where all the helices are straight, the A helix of LIF, OSM and CNTF is kinked [17,18].”
    Quote in the paperNot a substantial claim0 of 2 sources checked
    • cites [17]

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

    • cites [18]

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

  • Classified as probably not a substantial claim. 16
  • May combine two claims. 55
  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Interpretationreasoning

    The structural divergence of kinked versus straight cytokines might reflect differences in mechanisms of receptor recruitment, since straight cytokines signal via gp130 homodimers, whereas kinked cytokines signal via LIFR-gp130 or OSMR-gp130 heterodimers.

    “This structural divergence might reflect differences in the mechanisms of receptor recruitment, since the straight cytokines signal via gp130 homodimers, whereas the kinked cytokines signal via LIFR-gp130 or OSMR-gp130 heterodimers.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Premisecitation

    JAK1 plays an essential role, because in cells lacking JAK1 IL-6 signal transduction is greatly impaired.

    “Of these, JAK1 plays an essential role, because in cells lacking JAK1 IL-6 signal transduction is greatly impaired [51,52,134].”
    Quote in the paperSubstantial claim0 of 3 sources checked
    • cites [51]

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

    • cites [52]

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

    • cites [134]

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

  • Classified as probably not a substantial claim. May combine two claims.

    Interpretationcitation

    The bivalent intact antibody enforces receptor dimerization and the monovalent Fab adjusts the conformation required for JAK activation and downstream signalling.

    “This finding has been interpreted in a way that the bivalent intact antibody enforces receptor dimerization and the monovalent Fab adjusts the conformation required for JAK activation and downstream signalling [40].”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites [40]

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    Some evidence has been provided that under certain circumstances gp130 and LIFR are degraded after internalization.

    “Some evidence has been provided that under certain circumstances gp130 and LIFR are degraded after internalization [30][31][32].”
    Quote in the paperNot a substantial claim0 of 3 sources checked
    • cites [30]

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

    • cites [31]

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

    • cites [32]

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

  • May combine two claims.

    Premisecitation

    For gp130, the STATs depend on a specific conformation in order to become phosphorylated, whereas for the EpoR the receptor phosphorylation seems sensitive to changes in orientation.

    “While for gp130, the STATs were found to depend on a specific conformation in order to become phosphorylated, for the EpoR the receptor phosphorylation seems to be sensitive to changes in orientation.”
    Quote in the paperNot a substantial claim0 of 2 sources checked
    • cites [45]

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

    • cites [46]

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

  • May combine two claims.

    Premisecitation

    KSHV-IL-6 binds the gp130 homodimer in the absence of any α-receptor, but with lower affinity compared with IL-6-IL-6Rα-gp130 ternary complexes.

    “KSHV-IL-6 binds the gp130 homodimer in the absence of any α-receptor [16], but with lower affinity as compared with IL-6-IL-6Rα-gp130 ternary complexes.”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [16]

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

  • May combine two claims.

    Premisecitation

    Internalization of gp130 seems to be independent from ligand binding, and is modulated by phosphorylation at Ser782.

    “Internalization of gp130 seems to be independent from ligand binding [28], and is modulated by phosphorylation at Ser 782 [29] which is located adjacent to the dileucine motif.”
    Quote in the paperNot a substantial claim0 of 2 sources checked
    • cites [28]

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

    • cites [29]

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    ErbB2 forms a complex with gp130 in an IL-6-dependent manner in prostate carcinoma cells.

    “ErbB2 forms a complex with gp130 in an IL-6-dependent manner in prostate carcinoma cells [35].”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [35]

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    In certain cell types, gp130 localizes in plasma membrane microdomains, such as lipid rafts and caveolae.

    “In certain cell types, a localization of gp130 in plasma membrane microdomains, such as lipid rafts and caveolae, has been observed [9][10][11].”
    Quote in the paperNot a substantial claim0 of 3 sources checked
    • cites [9]

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

    • cites [10]

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

    • cites [11]

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

  • May combine two claims.

    Premisecitation

    After secretion of CLC-CLF-1 or CLC-CNTFRα complexes, signalling is dependent on CNTFRα and occurs via gp130-LIFR heterodimers.

    “After secretion of the CLC-CLF-1 or CLC-CNTFRα complexes, signalling is dependent on CNTFRα and occurs via gp130-LIFR heterodimers.”
    Quote in the paperNot a substantial claim0 of 2 sources checked
    • cites [12]

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

    • cites [13]

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

  • May combine two claims.

    Premisecitation

    Constantinescu et al. identified a hydrophobic motif in the EpoR membrane-proximal domain (Leu253, Ile257 and Trp258) which is conserved in many cytokine receptors and needs to be precisely orientated in order to promote signalling.

    “Constantinescu et al. [46] identified a hydrophobic motif in the EpoR membrane-proximal domain (Leu 253 , Ile 257 and Trp 258 ) which is conserved in many cytokine receptors and needs to be precisely orientated in order to promote signalling.”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [46]

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

  • May combine two claims.

    Premisecitation

    PKCδ enhances the association of STAT3 with the receptor, which possibly involves the phosphorylation of Thr890 of gp130.

    “PKCδ enhances the association of STAT3 with the receptor, which possibly involves the phosphorylation of Thr 890 of gp130 [67].”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [67]

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

  • May combine two claims.

    Premisecitation

    All IL-6-type cytokines potently activate STAT3, and to a minor extent STAT1, through their common receptor subunit gp130.

    “All IL-6-type cytokines potently activate STAT3, and to a minor extent STAT1 through their common receptor subunit gp130 [4].”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [4]

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

  • May combine two claims.

    Premisecitation

    The C-terminal tyrosine kinase domain of JAKs is preceded by a pseudokinase domain, which is devoid of catalytic activity but regulates the activity of the kinase domain.

    “The Cterminal tyrosine kinase domain is preceded by a pseudokinase domain, which itself is devoid of catalytic activity, but regulates the activity of the kinase domain [3].”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [3]

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

  • May combine two claims.

    Premisecitation

    In the cases of LIFR and OSMR, STAT3 and STAT1, as well as STAT5, activation has been observed, with OSMR being the most potent activator of STAT5.

    “In the cases of LIFR and OSMR, STAT3 and STAT1, as well as STAT5, activation has been observed, with OSMR being the most potent activator of STAT5 [56].”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [56]

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

  • May combine two claims.

    Premisecitation

    IL-6-induced STAT3 activation is MAPK independent, but sensitive to H7.

    “These results were confirmed by Chung et al. [105], who also observed that IL-6-induced STAT3 activation is MAPK independent, but sensitive to H7.”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [105]

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

  • May combine two claims.

    Premisecitation

    Cdk9 binds to gp130, and the association increases upon IL-6 stimulation of HEK 293 cells over-expressing gp130 and Cdk9.

    “Cdk9 (cyclin-dependent kinase 9) was also found to bind to gp130, and the association increased upon IL-6 stimulation of HEK 293 cells over-expressing gp130 and Cdk9 [66].”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [66]

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

  • May combine two claims.

    Premisecitation

    Deletion of amino acids 771-811 of gp130 reduces IL-6-induced Hck kinase activity, ERK activation, dephosphorylation of Pyk2 and proliferation of transfected pro-B Ba/F3 cells.

    “Deletion of these amino acids reduces IL-6-induced Hck kinase activity, ERK (extracellular-regulated kinase) activation, dephosphorylation of Pyk2 and proliferation of transfected pro-B Ba/F3 cells [65].”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [65]

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Interpretationcitation

    A conformational change in the SH2 domain may account for this dual specificity.

    “A conformational change in the SH2 domain may account for this dual specificity [91].”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [91]

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

  • May combine two claims.

    Premisecitation

    The recruitment of STATs to the activated receptors is mediated by their SH2 domain and requires the phosphorylation of receptor tyrosine motifs.

    “The recruitment of STATs to the activated receptors has been shown to be mediated by their SH2 domain and requires the phosphorylation of receptor tyrosine motifs [74,[81][82][83].”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites [74,[81][82][83]

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

  • May combine two claims.

    Premisecitation

    Substitution of Trp652 with alanine (W652A) within the box1 region of gp130 has no effect on JAK1 association but abrogates JAK1 activation.

    “substitution of Trp 652 with alanine (W652A) within the box1 region has no effect on JAK1 association but abrogates JAK1 activation.”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites [55]

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

  • May combine two claims.

    Interpretationcitation

    Mutations with similar consequences (no JAK activation in spite of JAK association) have been described for the EpoR, indicating that cytokine receptors in general contribute to the JAK-activation process.

    “Mutations with similar consequences (no JAK activation in spite of JAK association) have been described for the EpoR [59], indicating that cytokine receptors in general contribute to the JAK-activation process.”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites [59]

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

  • May combine two claims.

    Premisecitation

    Human fibrosarcoma cells lacking JAK1 express less OSMR at their surface compared with parental cells, but transient transfection of JAK1 can increase the amount of surface-expressed receptors.

    “human fibrosarcoma cells lacking JAK1 express less OSMR at their surface compared with the parental cells, but transient transfection of JAK1 can again increase the amount of surface-expressed receptors [49].”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites [49]

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

  • May combine two claims.

    Premisecitation

    Box2 of gp130 contributes to JAK binding, presumably by increasing the affinity; a gp130 construct lacking box2 coprecipitates with JAK1 only when the kinase is over-expressed.

    “Box2 of gp130, a sequence dominated by hydrophobic amino acids followed by charged ones, contributes to JAK binding, presumably by increasing the affinity; a gp130 construct lacking box2 coprecipitates with JAK1 only when the kinase is over-expressed [55].”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [55]

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

  • May combine two claims.

    Premisecitation

    This leads to the formation of active STAT dimers, also shown to be mediated by their SH2 domains.

    “This leads to the formation of active STAT dimers, also shown to be mediated by their SH2 domains [90].”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [90]

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

  • May combine two claims.

    Premisereasoning

    In response to IL-6, Gab1 is tyrosine phosphorylated and interacts with SHP2 and PI3K.

    “In response to IL-6, Gab1 is tyrosine phosphorylated and interacts subsequently with SHP2 and PI3K.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    A recent study on STAT3 activation in response to EGF suggests that receptor-mediated endocytosis is required for shuttling of STAT3 from the plasma membrane to the perinuclear region.

    “A recent study [112] on STAT3 activation in response to EGF (epidermal growth factor) suggests that receptor-mediated endocytosis is required for shuttling of STAT3 from the plasma membrane to the perinuclear region.”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [112]

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    In the DNA-binding domain of STAT1, initially an NES was postulated that comprises residues 399-410.

    “In the DNA-binding domain of STAT1, initially an NES was postulated that comprises residues 399-410 [108].”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [108]

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

  • May combine two claims.

    Premisecitation

    Compared with the unmethylated protein, methylated STAT1 has a higher tendency to associate with DNA, since its interaction with PIAS1 seems to be weaker.

    “Compared with the unmethylated protein, methylated STAT1 has a higher tendency to associate with DNA, since its interaction with PIAS (protein inhibitor of activated STATs) 1 (see the subsection below entitled 'PIAS -more than inhibitors of activated STATs?') seems to be weaker [106].”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [106]

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

  • May combine two claims.

    Premisecitation

    IL-6-type cytokines activate ERK1/2, p38 and JNK.

    “The family of IL-6-type cytokines not only activates ERK1/2, a MAPK known for cellular processes that maintain cell survival, but also the stress-activated members of the MAPK family: p38 and JNK [140-142] (Figure 6).”
    Quote in the paperNot a substantial claim0 of 3 sources checked
    • cites [140]

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

    • cites [141]

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

    • cites [142]

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

  • May combine two claims.

    Premisecitation

    Sensitivity to leptomycin suggests that nuclear export of STAT1 involves the nuclear export receptor CRM-1 that also acts in a Ran-dependent manner.

    “Sensitivity to leptomycin suggests that nuclear export of STAT1 involves the nuclear export receptor CRM-1 that also acts in a Randependent manner [108,109].”
    Quote in the paperNot a substantial claim0 of 2 sources checked
    • cites [108]

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

    • cites [109]

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

  • Classified as probably not a substantial claim.

    Premisecitation

    From an earlier study, it was concluded that nuclear translocation of STAT1 in response to IFNγ does not require cytoskeletal structures, such as actin filaments or microtubules.

    “However, from an earlier study [113], it was concluded that nuclear translocation of STAT1 in response to IFNγ does not require cytoskeletal structures, such as actin filaments or microtubules.”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites [113]

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

  • May combine two claims.

    Premisecitation

    SHP2 links the Grb2-SOS complex and/or Gab1 to gp130.

    “According to the current view of the SHP2-dependent activation of MAPKs adopted from EGF and PDGF (platelet-derived growth factor) signal transduction, SHP2 links the Grb2-SOS (growthfactor-receptor-bound protein/Son of Sevenless) complex and/or Gab1 (Grb2-associated binder-1) to gp130 [127,129,130].”
    Quote in the paperNot a substantial claim0 of 3 sources checked
    • cites [127]

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

    • cites [129]

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

    • cites [130]

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

  • May combine two claims.

    Premisecitation

    SOCS3 becomes tyrosine phosphorylated in response to IL-2, Epo, EGF and PDGF, binds and inactivates Ras/GTPase-activating protein, leading to sustained Ras/GTP and MAPK activity.

    “In response to IL-2, Epo, EGF, and PDGF, SOCS3 (suppressor of cytokine signalling 3) becomes tyrosine phosphorylated, and subsequently binds and inactivates Ras/GTPase-activating protein.This results in the inhibition of the GTPase activity of Ras, leading to a sustained Ras/GTP and MAPK activity [139].”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [139]

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

  • May combine two claims.

    Premisecitation

    SHP2 is rapidly recruited to tyrosine-phosphorylated gp130 and becomes phosphorylated in a JAK1-dependent manner.

    “SHP2 is rapidly recruited to tyrosine-phosphorylated gp130 and becomes also phosphorylated in a JAK1-dependent manner [131].”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [131]

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

  • May combine two claims.

    Premisenone given

    Dimerization of IL-6-type cytokine receptors leads to activation of the JAK/STAT-signalling pathway and to induction of the MAPK cascade.

    “Dimerization of IL-6-type cytokine receptors does not only lead to activation of the JAK/STAT-signalling pathway, but also to the induction of the MAPK cascade.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Premisecitation

    Nuclear accumulation of constitutively active STAT proteins is independent from endocytosis, because in these cases the STATs are not recruited to any plasma membrane receptor.

    “Furthermore, nuclear accumulation of constitutively active STAT proteins is independent from endocytosis, because in these cases the STATs are not recruited to any plasma membrane receptor [110,114].”
    Quote in the paperSubstantial claim0 of 2 sources checked
    • cites [110]

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

    • cites [114]

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

  • May combine two claims.

    Premisecitation

    PIAS1 inhibits STAT1 signalling but enhances the transcriptional activity of nuclear hormone receptors.

    “PIAS1 inhibits STAT1 signalling [179], but conversely enhances the transcriptional activity of nuclear hormone receptors [180].”
    Quote in the paperNot a substantial claim0 of 2 sources checked
    • cites [179]

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

    • cites [180]

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

  • May combine two claims.

    Premisecitation

    SHP2 modulates the amount and amplitude of STAT3 activity, whereas PTPεC affects the kinetics of onset of STAT3 activation.

    “Whereas SHP2 modulates the amount and amplitude of STAT3 activity [131,158], PTPεC affects the kinetics of the onset of STAT3 activation [169].”
    Quote in the paperNot a substantial claim0 of 3 sources checked
    • cites [131]

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

    • cites [158]

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

    • cites [169]

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

  • May combine two claims.

    Premisecitation

    PI3K activation upon IL-6 treatment is observed in a cell-type specific manner; no significant Akt activation is observed in IL-6-treated HepG2 hepatoma cells.

    “It should be noted, however, that PI3K activation upon IL-6 treatment is observed in a cell-type specific manner; e.g.no significant Akt activation could be observed in IL-6treated HepG2 hepatoma cells [149].”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [149]

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

  • May combine two claims.

    Premisenone given

    PI3K modifies phosphatidylinositides so that Akt is recruited to the plasma membrane and activated through phosphorylation by PDK1.

    “This enzyme modifies certain phosphatidylinositides, so that the serine/threonine kinase protein kinase B/Akt is recruited to the plasma membrane, where it becomes activated through phosphorylation by PDK1 (phosphoinositide-dependent kinase-1).”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Premisecitation

    A nuclear phosphatase counteracts IFNγ-activated STAT1 and contributes to its nuclear export.

    “Early results suggested the presence of a nuclear phosphatase which counteracts IFNγ -activated STAT1 and contributes to its nuclear export [121,173].”
    Quote in the paperNot a substantial claim0 of 2 sources checked
    • cites [121]

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

    • cites [173]

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

  • May combine two claims.

    Premisecitation

    Interaction of SHP2 with JAK1, JAK2 and TYK2, and phosphorylation of SHP2 by JAK1 and JAK2, occur in vitro.

    “Interaction of SHP2 with JAK1, JAK2 and TYK2, and phosphorylation of SHP2 by JAK1 and JAK2, have at least been shown to occur in vitro [131,162].”
    Quote in the paperNot a substantial claim0 of 2 sources checked
    • cites [131]

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

    • cites [162]

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

  • May combine two claims.

    Premisecitation

    IL-6-induced activation of the PI3K/Akt pathway is involved in protection against apoptosis and enhanced proliferation of multiple myeloma cells.

    “IL-6-induced activation of the PI3K/Akt pathway is involved in protection against apoptosis, as well as in enhanced proliferation of multiple myeloma cells [145][146][147].”
    Quote in the paperNot a substantial claim0 of 3 sources checked
    • cites [145]

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

    • cites [146]

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

    • cites [147]

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

  • May combine two claims.

    Premisecitation

    The cytoplasmic variant PTPεC is expressed in haematopoietic cells and selectively inhibits IL-6-induced gp130, JAK and STAT activation.

    “The cytoplasmic variant of PTPε, PTPεC, is expressed in haematopoietic cells and has been shown to selectively inhibit IL-6-induced gp130, JAK and STAT activation [168].”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [168]

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

  • May combine two claims.

    Interpretationreasoning

    IL-6-induced activation of the MAPK cascade is impaired by mutation of Tyr759 within gp130, indicating that SHP2 as an adaptor has a positive function on activation of the MAPK cascade.

    “On the other hand, the IL-6induced activation of the MAPK cascade is impaired by mutation of Tyr 759 within gp130, indicating that SHP2, as an adaptor, has a positive function on the activation of the MAPK cascade (as shown in Figure 1).”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisenone given

    The PIAS family comprises five mammalian members: PIAS1, PIAS3, PIASxα, PIASxβ, and PIASy.

    “The family of PIAS comprises five mammalian members: PIAS1, PIAS3, PIASxα, PIASxβ, and PIASy.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Interpretationreasoning

    Methylation supports STAT activity by preventing PIAS association and also promotes STAT inactivation by dephosphorylation.

    “Thus methylation not only supports STAT activity (by preventing PIAS association), but also promotes its inactivation by dephosphorylation.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Premisecitation

    Mice expressing gp130 lacking Tyr759 display splenomegaly, lymphadenopathy and an enhanced acute-phase reaction.

    “Experiments in vivo underscore the in vitro findings in demonstrating that mice expressing gp130 lacking Tyr 759 display splenomegaly, lymphadenopathy and an enhanced acute-phase reaction [161].”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites [161]

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

  • May combine two claims.

    Interpretationreasoning

    Differences in half-lives suggest that signalling components requiring posttranslational modifications for activation are long-lived, whereas the activity of short-lived proteins is regulated mainly at the transcriptional level.

    “These differences suggest that signalling components requiring posttranslational modifications for their activation are long-lived, whereas the activity of short-lived proteins is regulated mainly at the transcriptional level.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Premisecitation

    Feedback inhibitors SOCS1, SOCS2 and SOCS3 are very short-lived, whereas STAT1, STAT3α and SHP2 have slow turnover rates.

    “Whereas the feedback inhibitors SOCS1, SOCS2 and SOCS3 are very short-lived, STAT1, STAT3α and SHP2 have slow turnover rates.”
    Quote in the paperNot a substantial claim0 of 2 sources checked
    • cites [222]

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

    • cites [223]

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisenone given

    The eight members of the SOCS family (CIS and SOCS1-SOCS7) contain a central SH2 domain and a C-terminal SOCS box.

    “The eight members of this family (CIS and SOCS1-SOCS7) contain a central SH2 domain, as well as a C-terminal domain called a SOCS box (Figure 4).”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Premisecitation

    For gp130, SOCS3 binds to phosphotyrosine motif 759, which is also the binding site for SHP2.

    “For gp130, SOCS3 has been found to bind to the phosphotyrosine motif 759 [197,198], which is also the binding site for SHP2.”
    Quote in the paperNot a substantial claim0 of 2 sources checked
    • cites [197]

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

    • cites [198]

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

  • May combine two claims.

    Premisecitation

    Phosphorylation of SOCS3 occurs at Tyr204 and Tyr221 within the SOCS box, and phosphorylation of Tyr221 recruits p120 RasGAP leading to sustained ERK activation.

    “Phosphorylation occurs at two tyrosine residues (Tyr 204 and Tyr 221 ) within the SOCS box and phosphorylation of Tyr 221 recruits p120 RasGAP leading to sustained ERK activation [139].”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [139]

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Premisecitation

    Other reports suggest that elongin C binding can stabilize SOCS1 and that disruption of the interaction leads to proteasomal degradation of SOCS1.

    “Other reports, however, suggest that elongin C binding can stabilize SOCS1 and that the disruption of the interaction leads to proteasomal degradation of SOCS1 [206,215].”
    Quote in the paperNot a substantial claim0 of 2 sources checked
    • cites [206]

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

    • cites [215]

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

  • May combine two claims.

    Premisecitation

    Expression of SOCS proteins is rapidly up-regulated by IL-6 (CIS, SOCS1, SOCS2, SOCS3), LIF (CIS, SOCS1, SOCS2, SOCS3), IL-11 (SOCS3) and OSM (CIS, SOCS1, SOCS3).

    “Expression of SOCS proteins was found to be rapidly up-regulated by IL-6 (CIS, SOCS1, SOCS2 and SOCS3), LIF (CIS, SOCS1, SOCS2 and SOCS3), IL-11 (SOCS3) and OSM (CIS, SOCS1 and SOCS3) [32,190,192,193].”
    Quote in the paperNot a substantial claim0 of 3 sources checked
    • cites [32]

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

    • cites [190]

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

    • cites [192]

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

  • May combine two claims.

    Premisereasoning

    SOCS proteins are induced via the JAK/STAT pathway and subsequently inhibit STAT-mediated signal transduction, acting as classical feedback inhibitors.

    “As SOCS proteins are induced via the JAK/STAT pathway and subsequently inhibit STAT-mediated signal transduction, they are acting as classical feedback inhibitors.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Premisecitation

    The phosphotyrosine residues that release the SHP2 block may be part of an activated receptor or the tyrosine-phosphorylated C-terminal tail of SHP2.

    “These phosphotyrosine residues may be part of an activated receptor or the tyrosine-phosphorylated C-terminal tail of SHP2 (from [156]).”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [156]

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

  • May combine two claims.

    Premisecitation

    FKHR specifically enhances the activity of STAT3-dependent promoters, such as the α2M promoter, but not that of a STAT5-responsive promoter.

    “FKHR specifically enhanced the activity of STAT3-dependent promoters, such as the α 2 M promoter, but not that of a STAT5-responsive promoter.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    Other signalling pathways have been shown to induce stabilization of cytokine mRNAs.

    “Other signalling pathways have been shown to induce stabilization of cytokine mRNAs as well: the JNK pathway induces stabilization of the short-lived IL-2 mRNA [219], and PI3K activation induces stabilization of IL-3 mRNA [220].”
    Quote in the paperNot a substantial claim0 of 2 sources checked
    • cites [219]

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

    • cites [220]

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    PI3K activation induces stabilization of IL-3 mRNA.

    “PI3K activation induces stabilization of IL-3 mRNA [220]”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [220]

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

  • May combine two claims.

    Premisecitation

    SMRT is a potential binding partner for STAT5 and represses STAT5-dependent transcription.

    “The nuclear receptor co-repressor SMRT (silencing mediator of retinoic and thyroid hormone receptors) is a potential binding partner for STAT5 and represses STAT5-dependent transcription [255].”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [255]

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

  • May combine two claims.

    Premisecitation

    FKHR and STAT3 can be co-immunoprecipitated and co-localize in the nucleus of IL-6-treated HepG2 cells.

    “Furthermore, FKHR and STAT3 can be co-immunoprecipitated and co-localize in the nucleus of IL-6-treated HepG2 cells [149].”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites [149]

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    The JNK pathway induces stabilization of the short-lived IL-2 mRNA.

    “the JNK pathway induces stabilization of the short-lived IL-2 mRNA [219]”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [219]

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

  • May combine two claims.

    Premiseown data

    An EZI mutant predominantly localized in the cytoplasm inhibits nuclear localization of STAT3 and STAT3-mediated transactivation.

    “Interestingly, an EZI mutant predominantly localized in the cytoplasm inhibited nuclear localization of STAT3, as well as STAT3-mediated transactivation.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Interpretationcitation

    Nmi is induced by IL-2 and IFNγ, indicating a positive feedback loop within this signal transduction.

    “Interestingly, Nmi itself is induced by IL-2 and IFNγ , indicating a positive feedback loop within this signal transduction.”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [253]

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

  • May combine two claims.

    Premisecitation

    Nmi augments CBP recruitment to STAT1 and STAT5, and potentiates IL-2 and IFNγ signalling.

    “This interaction is further modulated by Nmi (N-Myc interactor) which augments CBP recruitment to STAT1 and STAT5, and potentiates IL-2 and IFNγ signalling [253].”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [253]

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

67 of 67
  • The authors state this as an assumption.

    The membrane-proximal FNIII domains bridge the ~9 nm distance between the CBM C-termini so that the cytoplasmic parts are close enough to become activated by associated JAKs.

    “The membrane-proximal FNIII domains might bridge this distance so that the cytoplasmic parts are in close enough proximity to become activated by the associated JAKs (Figure 5).This assumption is supported by a recent study on the role of the gp130 FNIII domains for heterodimerization with the LIFR [38].”
  • The paper relies on this without support.

    gp130 is ubiquitously expressed.

    “Although gp130 is ubiquitously expressed, the number of cells that respond to a certain IL-6-type cytokine is limited, since the expression of the other receptor subunits, especially of the α-receptors, is more restricted and tightly regulated.”
  • The paper relies on this without support.

    IL-6-type cytokines form a subfamily of helix bundle cytokines.

    “IL-6-type cytokines form a subfamily of the helix bundle cytokines.”
  • The paper relies on this without support.

    All IL-6-type cytokines comprise four long α-helices A-D arranged in an up-up-down-down topology.

    “All IL-6-type cytokines comprise four long α-helices termed A, B, C and D, which are arranged in a way that leads to an up-up-down-down topology (Figure 3).”
  • The paper relies on this without support.

    Each receptor contains at least one cytokine-binding module (CBM) comprising two FNIII domains.

    “Each receptor contains at least one cytokine-binding module (CBM) that comprises two FNIII-domains.”
  • The paper relies on this without support.

    JAKs bind to the membrane-proximal region of cytokine receptors, which contains conserved box1 and box2 motifs.

    “JAKs bind to the membrane-proximal region of cytokine receptors, which contains conserved so-called box1 and box2 motifs.”
  • The paper relies on this without support.

    The N-terminal region of JAKs comprises a FERM domain crucial for receptor association.

    “The N-terminal region of JAKs comprises a FERM (fourpoint-one, ezrin, radixin and moesin) domain which is crucial for receptor association.”
  • The paper relies on this without support.

    The STAT family encompasses seven mammalian members.

    “The STAT family of transcription factors encompasses seven mammalian members, designated STAT1, -2, -3, -4, -5a, -5b and -6.”
  • The paper relies on this without support.

    In response to IL-6 stimulation, cytoplasmic STAT3 rapidly accumulates in the nucleus.

    “In response to IL-6 stimulation, cytoplasmic STAT3 rapidly accumulates in the nucleus.”
  • The paper relies on this without support.

    Nuclear accumulation is triggered by STAT dimerization in response to tyrosine phosphorylation.

    “Nuclear accumulation is triggered by STAT dimerization in response to tyrosine phosphorylation.”
10 of 10

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • IL-6Rα expression is normally associated with hepatocytes and leukocytes but has also been described in cancer cells, including PDAC.

    “IL-6Rα expression is normally associated with hepatocytes and leukocytes but has also been described in cancer cells, including PDAC.”

    From Dynamic IL-6R/STAT3 signaling leads to heterogeneity of metabolic phenotype in pancreatic ductal adenocarcinoma cells (2024) · cites this paper as [40]

    The Introduction (page not available in our copy) says α-receptor expression is more restricted than gp130 expression, supporting the claim’s general point about limited distribution. It does not identify hepatocytes and leukocytes as the usual IL-6Rα-expressing cells. The PI3K section discusses IL-6 signalling in several cancer cell types, but does not establish IL-6Rα expression in those cells or mention PDAC. (LLM, conf=0.82)

    Experimental — accuracy not yet measured
  • The cytokine IL-6 triggers multiple downstream responses, including metabolic regulation.

    “The cytokine IL-6 triggers multiple downstream responses, including metabolic regulation.”

    From Dynamic IL-6R/STAT3 signaling leads to heterogeneity of metabolic phenotype in pancreatic ductal adenocarcinoma cells (2024) · cites this paper as [40]

    The Introduction (page not provided) describes multiple IL-6-type cytokine responses and signalling pathways, and the PI3K section specifically discusses effects of IL-6. The passages do not establish metabolic regulation as one of those responses; a search for that term and for glucose metabolism found no supporting passage. (LLM, conf=0.85)

    Experimental — accuracy not yet measured
  • IL-6 is a pleiotropic cytokine involved in immune responses, inflammation, hematopoiesis, bone metabolism, embryonic development and other fundamental processes.

    “IL-6, which was discovered in 1986 (27), is a pleiotropic cytokine involved not only in immune responses but also in inflammation, hematopoiesis, bone metabolism, embryonic development and other fundamental processes (1, 21, 28–32).”

    From IL-6 in inflammation, autoimmunity and cancer (2021) · cites this paper as [30]

    The Abstract and Introduction describe IL-6-type cytokines, a family that includes IL-6, as involved in immune responses, inflammation, haematopoiesis and embryonal development. The Abstract also links dysregulated signalling in this family to osteoporosis, but it does not specifically state that IL-6 itself is involved in bone metabolism or each of the other listed processes. (LLM, conf=0.83)

    Experimental — accuracy not yet measured

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
HEINRICH, P. C., BEHRMANN, I., HAAN, S., HERMANNS, H. M., MÜLLER-NEWEN, G., & SCHAPER, F.
Affiliations
  • Universitätsklinikum Aachen (DE)
  • Institut für Biochemie, RWTH Aachen, Universitätsklinikum, Pauwelsstrasse 30, D-52074 Aachen, Germany
Venue
Biochemical Journal
Published
2003-08-15
Volume
374
Issue
1
Pages
1-20
ISSN
  • 0264-6021 (ISSN-L)
  • 1470-8728
OpenAlex
W2086840459
Cited by
3,272
References
265
Citations by year
2026: 70 · 2025: 114 · 2024: 106 · 2023: 121 · 2022: 138 · 2021: 146 · 2020: 129 · 2019: 151 · 2018: 141 · 2017: 141 · 2016: 176 · 2015: 157 · 2014: 171 · 2013: 190 · 2012: 179
FWCI
50.93
Type
journal article
Language
en
Open access
Locations
  • Biochemical Journal (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (submittedVersion)
  • Open Repository and Bibliography (University of Luxembourg) (submittedVersion)
  • RWTH Publications (RWTH Aachen) (submittedVersion)
Funders
Deutsche Forschungsgemeinschaft
Topics
  • Health Sciences › Medicine › Oncology › Cytokine Signaling Pathways and Interactions
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Tyrosine Phosphatases
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
Keywords
cytokine signaling, gp130, LIF receptor, OSM receptor, JAK/STAT signaling, MAPK signaling, protein tyrosine phosphatase, suppressor of cytokine signaling, PIAS, signal termination, signal transduction, acute phase response, inflammation, rheumatoid arthritis, multiple myeloma, prostate cancer
MeSH terms
Animals, Humans, Infections, Models, Molecular, Phosphorylation, Protein Conformation, Wounds and Injuries, Signal Transduction, Interleukin-6, Cytokines, Protein Structure, Secondary, Receptors, Interleukin-6

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-23.

Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-23.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review